China Pediatric Pharmaceuticals, Inc. (CPDU) Return on Investment ROI from the first quarter of 2014 to first quarter of 2013 and for the year 2014, average high and low, overall ranking from Mar 31 2014 to Mar 31 2013 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Pediatric Pharmaceuticals, Inc.  (CPDU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


China Pediatric Pharmaceuticals,'s ROI from its first quarter of 2014 to the first quarter of 2013 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is China Pediatric Pharmaceuticals,'s ROI in the first quarter of 2014?
China Pediatric Pharmaceuticals, Inc. achieved a return on average invested assets (ROI) of 30.39 % in its first quarter of 2014 a new company high.

Despite the deterioration in its net income, company has improved ROI compared to the fourth quarter of 2013.

Within the Healthcare sector 12 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2013 from 0 to 124.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter
Y / Y Investment Change TTM -37.7 % -53.6 % -58.77 % -53.65 % -46.57 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 10 11 6 6 7
Return On Investment (TTM) 30.39 % -10.18 % -126.63 % -130.54 % -93.19 %
CPDU's Overall Ranking # 124 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 9.04 % -1.31 % -23.5 % -24.32 % -18.79 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 2 -1 -10 -13 -12

CPDU Company Profile >> Back to CPDU Roi Comparisons >> See Annual CPDU Return On Investment



Return On Investment CPDU's Ranking
Within: No.
Industry # 0
Sector # 13
Overall # 124

Return On Investment Statistics
High Average Low
30.39 %
-60.72 %
-130.54 %
(Mar 31 2014)   (Jun 30 2013)







Financial Statements
China Pediatric Pharmaceuticals,'s I. Quarter Investments $ 10 Millions CPDU's Balance sheet
China Pediatric Pharmaceuticals,'s I. Quarter Income $ -2 Millions Quarterly CPDU's Income Statement
CPDU's Income by Division See CPDU's Income by Division


CPDU Annual Return On Investment (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2010)
2011

Total Investments in Millions 11 12 24 0 0
Y / Y Investment Growth -3.38 % -50.8 % - - -
Net Income in Millions -1 -9 6 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -6.74 % -78.77 % 25.28 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CPDU's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CPDU's Competitors
Subscribers only: Roi for China Pediatric Pharmaceuticals,'s Suppliers
Subscribers only: Return On Investment for CPDU's Customers

Other Ratios
CPDU's Roa CPDU's Inventory Turnover Ratio CPDU's Growth Rates CPDU's Dividend Statistics
CPDU's Profitability Ratios CPDU's Asset Turnover Ratio CPDU's Dividend Growth
CPDU's Roe CPDU's Valuation Ratios CPDU's Financial Strength Ratios CPDU's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2014, within Healthcare Sector ROI
Epizyme Inc.  82.44 %
Histogen Inc   80.72 %
Iveric Bio Inc   77.83 %
Eternity Healthcare Inc.  74.89 %
Filana Therapeutics Inc   63.31 %
Arena Pharmaceuticals Inc   62.71 %
Guided Therapeutics Inc   60.48 %
Lightwave Logic Inc   55.94 %
Icagen, Inc.  54.00 %
Sonoma Pharmaceuticals Inc   48.79 %
Insys Therapeutics, Inc.  46.54 %
Agios Pharmaceuticals Inc   46.53 %
Lftd Partners Inc   45.65 %
Portola Pharmaceuticals inc   44.71 %
Oramed Pharmaceuticals Inc  38.89 %
Oncomed Pharmaceuticals Inc  37.06 %
Milestone Scientific Inc   35.93 %
Taro Pharmaceutical Industries Ltd  35.00 %
Sorrento Therapeutics Inc   32.12 %
Luna Innovations Inc  31.22 %
Veru Inc   30.86 %
China Pediatric Pharmaceuticals, Inc.  30.39 %
Sunwin Stevia International Inc.  29.86 %
Psychemedics Corporation  27.93 %
Bioage Labs Inc   25.98 %
Myriad Genetics Inc   25.94 %
China Biologic Products Holdings Inc   25.56 %
Idexx Laboratories Inc  25.15 %
Gilead Sciences Inc   24.95 %
Assertio Holdings inc   24.10 %

Date modified: 2026-09-08T15:08:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.